Journal of Drug Abuse Open Access

  • ISSN: 2471-853X
  • Journal h-index: 10
  • Journal CiteScore: 1.81
  • Journal Impact Factor: 1.92
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Articles published in Journal of Drug Abuse have been cited by esteemed scholars and scientists all around the world. Journal of Drug Abuse has got h-index 10, which means every article in Journal of Drug Abuse has got 10 average citations.

Following are the list of articles that have cited the articles published in Journal of Drug Abuse.

  2022 2021 2020 2019 2018 2017 2016

Year wise published articles

65 62 34 13 12 26 32

Year wise citations received

77 70 58 58 39 31 14
Journal total citations count 362
Journal impact factor 1.92
Journal 5 years impact factor 1.41
Journal cite score 1.81
Journal h-index 10
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
Pant A, Lim M. Checkpoint blockade in recurrent meningiomas: Lessons for future management. Neuro-oncology. 2021 Oct 9.
Bravaccini S, Bronte G, Ulivi P. TMB in NSCLC: A Broken Dream?. International Journal of Molecular Sciences. 2021 Jan;22(12):6536.
Hill CS, Devesa SC, Ince W, Borg A, Aquilina K. A systematic review of ongoing clinical trials in optic pathway gliomas. Child's Nervous System. 2020 Jun 18:1-8.
Chew GL, Bleakley M, Bradley RK, Malik HS, Henikoff S, Molaro A, Sarthy J. Short H2A histone variants are expressed in cancer. Nature Communications. 2021 Jan 20;12(1):1-9.
Dias MH, Bernards R. Playing cancer at its own game: activating mitogenic signaling as a paradoxical intervention. Molecular Oncology. 2021 Aug;15(8):1975-85.
Peterson M, Murphy SN, Lainson J, Zhang J, Shen L, Diehnelt CW, Johnston SA. Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model. BMC immunology. 2020 Dec;21:1-5.
Oka M, Xu L, Suzuki T, Yoshikawa T, Sakamoto H, Uemura H, Yoshizawa AC, Suzuki Y, Nakatsura T, Ishihama Y, Suzuki A. Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer. Genome biology. 2021 Dec;22(1):1-30.
Han XJ, Ma XL, Yang L, Wei YQ, Peng Y, Wei XW. Progress in neoantigen targeted cancer immunotherapies. Frontiers in Cell and Developmental Biology. 2020 Jul 30;8:728.
Hershberger CE, Moyer DC, Adema V, Kerr CM, Walter W, Hutter S, Meggendorfer M, Baer C, Kern W, Nadarajah N, Twardziok S. Complex landscape of alternative splicing in myeloid neoplasms. Leukemia. 2021 Apr;35(4):1108-20.
Liu J, Xu M, Yuan Z. Immunoscore guided cold tumors to acquire “temperature” through integrating physicochemical and biological methods. BIO Integration. 2020 Jun 7;1(1):6-14.
Chru?ciel E, Urban-Wójciuk Z, Arcimowicz ?, Kurkowiak M, Kowalski J, Gliwi?ski M, Marja?ski T, Rzyman W, Biernat W, Dziadziuszko R, Montesano C. Adoptive cell therapy—harnessing antigen-specific T cells to target solid tumours. Cancers. 2020 Mar;12(3):683.
Arnaud M, Duchamp M, Bobisse S, Renaud P, Coukos G, Harari A. Biotechnologies to tackle the challenge of neoantigen identification. Current opinion in biotechnology. 2020 Oct 1;65:52-9.
Vinichenko MV, Rybakova MV, Vinogradova MV, Malyshev MA, Maksimov AA. The Effect of Digital Economy and Artificial Intelligence on The Participants of The School Educational Process. Propósitos y Representaciones. 2020 Sep 1;8(SPE2):694.
Nahavandi S. Industry 5.0—A human-centric solution. Sustainability. 2019 Jan;11(16):4371.
Soro DB, Carrobles JA, García MA. Reducción del estigma, la depresión y la ansiedad en personas con VIH mediante un grupo terapéutico cognitivo conductual. Psicología conductual= behavioral psychology: Revista internacional de psicología clínica y de la salud. 2021;29(2):237-57.
Biel Soro D, Antonio Carrobles J, García MA. REDUCING STIGMA, DEPRESSION AND ANXIETY IN PEOPLE WITH HIV THROUGH A COGNITIVE BEHAVIORAL THERAPY GROUP. Behavioral Psychology/Psicologia Conductual. 2021 May 1;29(2).
Khan SI, Khan MN, Hasan AR, Irfan SD, Horng LM, Chowdhury EI, Azim T. Understanding the reasons for using methamphetamine by sexual minority people in Dhaka, Bangladesh. International Journal of Drug Policy. 2019 Nov 1;73:64-71.
Stirbinskas S. Deviantin?s etiket?s poveikis rekreacines kanapes vartojantiems pilname?iams asmenims.
Baum MK, Tamargo JA, Wanke C. Nutrition in HIV and Tuberculosis. InNutrition and Infectious Diseases 2021 (pp. 243-281). Humana, Cham.
Jiang W, Luo Z, Martin L, Wan Z, Fu P, Wagner A, Ling B, Heath SL, Haque A, McRae-Clark A. Drug use is associated with anti-CD4 IgG-mediated CD4+ T cell death and poor CD4+ T cell recovery in viral-suppressive HIV-infected individuals under antiretroviral therapy. Current HIV research. 2018 Mar 1;16(2):143-50.